Real-time enrollment status for this recurrent or metastatic solid tumors clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 6:30 AM UTC
| NCT Number | NCT07015697 |
| Recruiting Status | Recruiting |
| Condition | Recurrent or Metastatic Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 76 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Daiichi Sankyo |
| Last Updated on CT.gov | July 9, 2026 (Jul 9, 2026) |
As of August 28, 2026: Clinical trial NCT07015697 is currently recruiting participants. This phase1 study for recurrent or metastatic solid tumors is actively seeking new participants at 6 locations across the United States. The study is sponsored by Daiichi Sankyo. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07015697 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07015697 was last updated Jul 9, 2026 (July 9, 2026). HelloStudys verifies this status automatically.